TNT to Increase the Clinical Complete Response Rate for Distal LARC

NCT03840239 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
Rectal Cancer Stage II
Rectal Cancer Stage III
Chemoradiation

Interventions

DRUG: Capecitabine, Oxaliplatin
RADIATION: External beam radiotherapy
PROCEDURE: Surgery
OTHER: Watch and wait strategy

Sponsor

Sun Yat-sen University